Contineum Therapeutics, Inc.·4

Jan 31, 4:41 PM ET

Healy John Stephen 4

4 · Contineum Therapeutics, Inc. · Filed Jan 31, 2025

Insider Transaction Report

Form 4
Period: 2025-01-31
Healy John Stephen
General Counsel and Corp Sec
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-31+63,58963,589 total
    Exercise: $9.79Exp: 2035-01-30Class A Common Stock (63,589 underlying)
Footnotes (1)
  • [F1]Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on January 1, 2026, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4